Annabidiol Corp.
ACBD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $104 | $14 | $30 | $26 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $104 | $14 | $30 | $26 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 566.7% | -98% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | – | 1,578.7% | -902.7% | 86.1% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | – | -100.3% | -902.3% | 86.1% |
| EPS Diluted | -0.003 | -0 | -0 | 0.002 |
| % Growth | -1,000% | 0% | -118.8% | – |
| Operating Cash Flow | – | -$0 | -$0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | $0 |